RDHL
Redhill Biopharma Ltd
NASDAQ: RDHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
+0.00% today
Updated 2026-04-29
Market cap
$5.27M
P/E ratio
0.00
P/S ratio
0.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Redhill Biopharma Ltd (RDHL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $23000.00 | $16000.00 | $12000.00 | $7.01M | $3000.00 | $101000.00 | $4.01M | $8.36M | $6.29M | $64.36M | $85.76M | $61.80M | $6.53M | $8.04M |
| Revenue growth (YoY) | — | — | -30.4% | -25.0% | +58350.0% | -100.0% | +3266.7% | +3867.3% | +108.6% | -24.7% | +923.0% | +33.2% | -27.9% | -89.4% | +23.2% |
| Cost of revenue | — | $7.88M | $9.03M | $10.76M | $1.05M | $22.00M | $30.54M | $2.13M | $2.84M | $2.26M | $36.89M | $49.41M | $33.34M | $3.46M | $3.19M |
| Gross profit | — | $23000.00 | $16000.00 | $12000.00 | $5.96M | $-22.00M | $-30.44M | $1.88M | $5.52M | $4.03M | $27.47M | $36.35M | $28.46M | $3.07M | $4.85M |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 85.0% | -733300.0% | -30140.6% | 46.9% | 66.1% | 64.1% | 42.7% | 42.4% | 46.1% | 47.0% | 60.3% |
| R&D | $736000.00 | $5.41M | $6.46M | $8.10M | $12.70M | $17.77M | $25.24M | $32.97M | $24.86M | $17.42M | $16.49M | $29.50M | $7.28M | $3.53M | $1.59M |
| SG&A | $518000.00 | $2.48M | $2.60M | $2.68M | $4.01M | $3.98M | $5.16M | $8.03M | $7.51M | $11.48M | $25.38M | $76.60M | $54.97M | $28.88M | $14.52M |
| Operating income | $-1.73M | $-7.87M | $-9.04M | $-10.77M | $-10.65M | $-22.00M | $-30.54M | $-51.97M | $-39.33M | $-43.20M | $-63.68M | $-81.14M | $-42.84M | $12.63M | $-14.61M |
| Operating margin | — | -34230.4% | -56500.0% | -89766.7% | -151.8% | -733400.0% | -30240.6% | -1297.0% | -470.5% | -686.7% | -99.0% | -94.6% | -69.3% | 193.4% | -181.7% |
| EBITDA | $-2.55M | $-7.86M | $-9.02M | $-10.75M | $-10.62M | $-21.97M | $-30.50M | $-45.46M | $-38.73M | $-40.70M | $-54.98M | $-63.03M | $-22.18M | $26.27M | $-7.59M |
| EBITDA margin | — | -34165.2% | -56350.0% | -89566.7% | -151.4% | -732200.0% | -30197.0% | -1134.6% | -463.3% | -647.0% | -85.4% | -73.5% | -35.9% | 402.3% | -94.4% |
| EBIT | $-2.49M | $-7.87M | $-9.04M | $-10.77M | $-10.65M | $-22.00M | $-30.54M | $-45.54M | $-38.82M | $-41.91M | $-63.72M | $-81.18M | $-30.34M | $24.28M | $-8.21M |
| Interest expense | $876000.00 | $65000.00 | $1.48M | $14000.00 | $22000.00 | $12000.00 | $7000.00 | $77000.00 | $167000.00 | $439417.00 | $12.45M | $16.57M | $41.33M | $367000.00 | $55000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.54M | $-15.50M | $-10.33M | $-10.63M | $-10.71M | $-21.09M | $-29.37M | $-45.54M | $-38.82M | $-42.30M | $-76.17M | $-97.74M | $-71.67M | $23.92M | $-8.27M |
| Net income growth (YoY) | — | -509.4% | +33.4% | -2.9% | -0.8% | -96.9% | -39.3% | -55.1% | +14.8% | -9.0% | -80.1% | -28.3% | +26.7% | +133.4% | -134.6% |
| Profit margin | — | -67404.3% | -64537.5% | -88566.7% | -152.7% | -703000.0% | -29079.2% | -1136.6% | -464.4% | -672.5% | -118.4% | -114.0% | -116.0% | 366.2% | -102.8% |